首頁 › 急性髓系白血病 › 加州 › Baldwin Park
Baldwin Park, CA 的 急性髓系白血病 臨床試驗
40 項針對 急性髓系白血病 的研究正在 Baldwin Park（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
招募中2/3 期
- City of Hope National Medical Center /ID# 279568, Duarte · 距離 4 英里
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
招募中1 期
- City of Hope, Duarte · 距離 4 英里
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
招募中1 期
- City of Hope Medical Center, Duarte · 距離 4 英里
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
招募中3 期
- Clinical Trial Site, Duarte · 距離 4 英里
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
招募中3 期
- City of Hope, Duarte · 距離 4 英里
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
招募中3 期
- City of Hope Comprehensive Cancer Center, Duarte · 距離 4 英里
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
招募中2 期
- City of Hope Comprehensive Cancer Center, Duarte · 距離 4 英里
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
招募中1 期
- City of Hope National Medical Center, Duarte · 距離 4 英里
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
招募中1/2 期歡迎健康志工
- City of Hope, Duarte · 距離 4 英里
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
招募中1/2 期
- City of Hope Comprehensive Cancer Center, Duarte · 距離 4 英里
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
招募中1/2 期
- City of Hope National Medical Center, Duarte · 距離 4 英里
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
招募中1 期
- City of Hope Medical Center, Duarte · 距離 4 英里
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
招募中1 期
- City of Hope, Duarte · 距離 4 英里
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
招募中1 期
- City of Hope Medical Center, Duarte · 距離 4 英里
Individualized AML Treatment
招募中觀察性研究
- City of Hope Medical Center, Duarte · 距離 4 英里
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
招募中2 期
- City of Hope Medical Center, Duarte · 距離 4 英里
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
招募中1 期
- City of Hope Medical Center, Duarte · 距離 4 英里
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
招募中1 期歡迎健康志工
- City of Hope Medical Center, Duarte · 距離 4 英里
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
招募中3 期
- City of Hope Comprehensive Cancer Center - Duarte, Duarte · 距離 4 英里
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
招募中1 期
- City of Hope Medical Center, Duarte · 距離 4 英里
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- City of Hope, Duarte · 距離 4 英里
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
招募中1 期
- City of Hope Medical Center, Duarte · 距離 4 英里
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
招募中2 期
- City of Hope Medical Center, Duarte · 距離 4 英里
A Study of Revumenib and Mezigdomide in People With Leukemia
招募中1/2 期
- City of Hope Cancer Center (Data collection only), Duarte · 距離 4 英里
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
招募中1 期
- City of Hope, Duarte · 距離 4 英里
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
招募中1 期歡迎健康志工
- City of Hope Medical Center, Duarte · 距離 4 英里
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
招募中1 期
- City of Hope, Duarte · 距離 4 英里
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
招募中1 期
- City of Hope Medical Center, Duarte · 距離 4 英里
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
招募中2 期
- City of Hope, Duarte · 距離 4 英里
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
招募中1 期
- City of Hope, Duarte · 距離 4 英里
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
招募中2 期歡迎健康志工
- City of Hope Medical Center, Duarte · 距離 4 英里
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
招募中1 期
- City of Hope Medical Center, Duarte · 距離 4 英里
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
招募中1 期
- City of Hope Medical Center, Duarte · 距離 4 英里
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
招募中1 期
- City of Hope Medical Center, Duarte · 距離 4 英里
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
招募中1 期
- City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 距離 4 英里
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
招募中2 期
- City of Hope Medical Center, Duarte · 距離 4 英里
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
招募中1 期
- City of Hope - Duarte, Duarte · 距離 4 英里
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
招募中1 期
- City of Hope Medical Center, Duarte · 距離 4 英里
Study of REM-422 in Patients With AML or Higher Risk MDS
招募中1 期
- City of Hope, Duarte · 距離 4 英里
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
招募中1 期
- City of Hope National Medical Center, Duarte · 距離 4 英里
其他城市的 急性髓系白血病 試驗
- Houston, TX85 項研究
- New York City, NY51 項研究
- Boston, MA44 項研究
- Seattle, WA41 項研究
- Columbus, OH35 項研究
- Philadelphia, PA34 項研究
- Durham, NC33 項研究
- Atlanta, GA31 項研究
- Tampa, FL29 項研究
- Chicago, IL26 項研究
- Portland, OR25 項研究
- Washington, DC24 項研究
Baldwin Park 的其他研究
- 乳癌44 項研究
- 大腸直腸癌37 項研究
- 非小細胞肺癌36 項研究
- 癌症（所有類型）34 項研究
- 前列腺癌30 項研究
- 轉移性癌症30 項研究
- 骨髓增生異常症候群26 項研究
- 卵巢癌25 項研究
- 肺癌24 項研究
- 多發性骨髓瘤23 項研究
- 胃癌22 項研究
- 急性淋巴母細胞性白血病21 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。